top of page
Copy of Vibrant IP.png

Accelerating Innovation to Market: How GMDx Genomics is Partnering with Vibrant IP to Unlock the Value of Its Patent Portfolio

Writer: Sydney Olsen
Sydney Olsen
Oct 6
4 min read

Updated: Oct 9

Customer Spotlight | Vibrant IP


For life sciences innovators, a strong patent portfolio can be one of the most valuable assets a

company holds. Turning that portfolio into a real transaction, whether a sale, license, or

strategic partnership, takes more than a listing. It takes preparation, positioning, and access to

the right decision makers at the right time.


GMDx Genomics is working with Vibrant IP to do exactly that: monetize its IP. With positive

initial interest in its offering, Bernie Romanin, CEO and Director of GMDx Genomics, shared

why the company chose Vibrant IP.


“What stands out is the depth of the team. You're not handing your IP to a single

broker. You're getting a full group of experienced professionals who understand the

science, the patents, and the business case, and who know how to get in front of

the people who actually make decisions.”

— Bernie Romanin, CEO and Director, GMDx Genomics



A Trusted Recommendation from the Capital Side


Matthew Kilpatrick, Founder and Strategic Corporate Adviser at GMDx Genomics, brings a

capital partner's view to the relationship. Having worked with a range of technology startups, he

has seen firsthand how difficult it can be for young companies to monetize their patented

technologies. It is one key reason why he recommended Vibrant IP to GMDx.


“In my experience with early-stage companies, the patents are often where much of

the value sits, but most founders don't have the time, networks, or specialist

knowledge to realize it.”

— Matthew Kilpatrick, Founder and Strategic Corporate Adviser, GMDx Genomics



Choosing a Specialist for a Life Sciences Estate


GMDx Genomics holds a patent estate in precision oncology, built on methods that attribute the

mutations in a tumor to the enzymes that caused them. For an estate of that kind, the company

wanted a partner whose experience was in medical, pharmaceutical, and biotech transactions

rather than in patents generally.


“In life sciences, credibility with the buyer matters enormously. We wanted a partner

whose track record and relationships were in pharma, biotech, and diagnostics, and

whose process would stand up to the way those organizations evaluate technology.

That focus was the reason we engaged Vibrant IP.”

— Bernie Romanin



Focus and Direction in Reaching the Market


For Bernie Romanin, the value of Vibrant IP's approach has been its direction: outreach aimed

at the organizations where the technology is most relevant, run through a structured process.


“Vibrant IP moved quickly, and more importantly, they moved in the right direction.

Their outreach is focused on the companies where our technology is most relevant,

and it is aimed at the people in those companies who make decisions.”

— Bernie Romanin


“The process is structured the way a serious acquirer expects: public materials first,

then a mutual NDA, then the confidential data room and direct access to our

scientific team. Having that in place before outreach starts is what makes the

conversations productive.”

— Bernie Romanin



A Comprehensive, Team-Based Approach


Behind the GMDx engagement is a dedicated team of Vibrant IP professionals, each

contributing to a different stage of the process:


• IP readiness and preparation: reviewing and positioning the portfolio so it is ready to be

offered with clarity and credibility.

• Marketing the IP: developing materials that communicate the technology's value to

technical and business audiences alike.

• Data room preparation: organizing the documentation serious buyers and licensees

expect during evaluation and diligence.

• Buyer and licensee identification: mapping the market to find the organizations with the

strongest strategic fit.

• Qualification and outreach: vetting prospective counterparties and engaging them

directly, often at the executive level.

• Ongoing transaction support: providing a range of additional services as opportunities

develop.


This end-to-end model makes Vibrant IP's offering one of the most comprehensive in the patent

brokering marketplace.


“The model is genuinely full-service, from readiness through the data room to

qualification and outreach. For a company of our size, having one team carry the

whole process matters.”

— Bernie Romanin



Deep Roots in Medical, Pharmaceutical, and Biotech


Vibrant IP has long been a leader in patent transactions across the medical, pharmaceutical,

and biotech sectors. That history gives the team a clear understanding of how these industries

evaluate technology, and the relationships to reach leaders across them.



Looking Ahead


GMDx Genomics is running a structured sale process for its patent estate through Vibrant IP,

and will evaluate what the process produces alongside its corporate objectives.

“Vibrant IP gives a company of our size a route to the acquirers that matter for this

technology, run as a structured process. We will consider what it produces carefully

as we continue to execute on our strategy.”

— Bernie Romanin



About GMDx Genomics


GMDx Genomics (GMDx Group Ltd) is a Melbourne, Australia based precision-oncology

company. Its patented codon-context methods attribute somatic mutations in a tumor to the

deaminase enzymes that caused them, and its Immune Fitness Profile (IFP) uses those

signatures to predict response to cancer immunotherapy, with validation in four non-small cell

lung cancer studies. The patent estate comprises 45 active patent assets across 11 national

jurisdictions plus European Patent coverage, with priority from November 2012, supported by

the CRIS (Codon Reference Information System) analytical platform. GMDx is offering the

estate to a strategic acquirer through Vibrant IP. Company contact: Bernie Romanin, CEO.

Inquiries about the patent estate: Vibrant IP, LLC, reference VIP-3622.



About Vibrant IP


Vibrant IP helps innovators, startups, and established companies realize the value of their

patented technologies through transaction readiness, marketing, data room preparation, and

targeted buyer and licensee outreach. With deep expertise in medical, pharmaceutical, and

biotech technologies, Vibrant IP connects patent owners with executive decision makers across

industries.


Learn more at vibrantip.com

 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page